Daily non-political popular news in brief.
Tumor-targeting viral therapy slows neuroblastoma, malignant peripheral nerve sheath tumors
02-15-2008 · EurekAlert!Researchers in a multi-institutional study led by Cincinnati Children's Hospital Medical Center slowed the growth of two particularly stubborn solid tumor cancers -- neuroblastoma and peripheral nerve sheath tumors -- without harming healthy tissues by inserting instructions to inhibit tissue growth into an engineered virus, according to study results published in the Feb. 15 Cancer Research.
Read more »
Keywords: tumor-targeting, viral, therapy, slows, neuroblastoma, malignant, peripheral, nerve, sheath, tumors, tumor, targeting, slow
« Previous | Next »
Similar news on "Tumor-targeting viral therapy slows neuroblastoma, malignant peripheral nerve sheath tumors":
- Targeting astrocytes slows disease progression in ALS
02-03-2008 · EurekAlert!
In what the researchers say could be promising news in the quest to find a therapy to slow the progression of amyotrophic lateral sclerosis, or Lou Gehrig's disease, scientists at the University of California, San Diego School of Medicine have shown that targeting neuronal support cells called astrocytes sharply slows disease progression in mice.
Similar news · Read more »
- Animal study identifies promising new target for brain tumor therapy
05-08-2007 · EurekAlert!
A drug that targets the body's immune cells may be effective in treating malignant brain tumors, according to a new study led by researchers from Duke's Preston Robert Tisch Brain Tumor Center. In animal models, the drug re-engaged the body's cancer-damaged immune system.
Similar news · Read more »
- Bits of 'junk' RNA aid master tumor-suppressor gene
08-23-2007 · EurekAlert!
A University of Michigan study reveals that the p53 gene, a key protector mutated in half of all cancers, gets help in its vital job of stifling tumors from a trio of little-known micro RNA genes. Drugs that mimic their benefits could become important tools in cancer therapy someday.
Similar news · Read more »
- Killing brain tumors from within: A 'Trojan horse' approach
10-24-2006 · EurekAlert!
A new method for targeting malignant brain tumors through inducing the cancerous cells to "commit suicide" has been developed by a team of researchers headed by a Hebrew University of Jerusalem professor of biochemistry.
Similar news · Read more »
- Bevacizumab found to improve survival for patients with advanced breast cancer
12-26-2007 · EurekAlert!
Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer according to results of a large clinical trial of Avastin, an antiangiogenic therapy. The study, published in the Dec. 27 issue of the New England Journal of Medicine, found that Avastin in combination with chemotherapy significantly prolongs progression-free survival for women with breast cancer compared to chemotherapy alone.
Similar news · Read more »
- Therapeutic peptide frees the protein p73 to kill tumor cells
03-08-2007 · EurekAlert!
p53 suppresses tumor development by inducing tumor cell death. However, targeting p53 for the treatment of cancer is confounded by the fact that genetic mutations cause loss or inactivation of p53 in approximately 50 percent of human cancers. Now, a new study indicates that targeting the p53-related protein p73 in mice induces the regression of established tumors of human origin, leading to the suggestion that p73 might be a viable target for developing anticancer therapeutics.
Similar news · Read more »
- Scripps research combination therapy obliterates new vessel growth in tumors and retinopathy
01-09-2007 · EurekAlert!
Using a new and dramatically effective treatment approach, scientists at the Scripps Research Institute have for the first time achieved complete inhibition of new blood vessel growth in animal models of a highly vascular brain tumor and of neovascular eye diseases with little or no effect on normal tissue vasculature.
Similar news · Read more »
- Fat kills cancer
07-03-2007 · EurekAlert!
Researchers in Slovakia have been able to derive mesenchymal stem cells from human adipose, or fat, tissue and engineer them into "suicide genes" that seek out and destroy tumors like tiny homing missiles. This gene therapy approach is a novel way to attack small tumor metastases that evade current detection techniques and treatments, the researchers conclude in the July 1 issue of Cancer Research, a journal of the American Association for Cancer Research.
Similar news · Read more »
- Penn researchers identify new combination therapy that promotes cancer cell death
07-16-2007 · EurekAlert!
To test the ability of combined therapy, researchers administered TRAIL, a tumor necrosis factor, and sorafenib, an inhibitor currently used to treat renal cancer, to mice with colon carcinomas. It reduced the size of tumors in mice with few side effects
Similar news · Read more »
- How 'IAP antagonist' chemicals kill tumors
11-15-2007 · EurekAlert!
Chemical compounds specially designed to neutralize proteins that would otherwise allow tumor cells to cheat death have been recognized for some time by scientists as a promising new avenue for cancer therapy. Now, two studies in the Nov. 16, 2007 issue of the journal Cell, a publication of Cell Press, provide insight into just how these antagonists of the anti-death -- so-called Inhibitor-of-Apoptosis (IAP) -- proteins work to fight tumors.
Similar news · Read more »
